流行性/季節性インフルエンザのワクチン製造技術

As a total solutions provider, Pall is working closely with its customers to assist them with the efficient, rapid manufacture of pandemic influenza vaccines.Pall technologies are in use in the production of almost all commercially-available seasonal influenza vaccines, and utilizing this expertise and our state-of-the-art technologies, we can support our customers all the way from the development stages right through to manufacture and product release.

In addition, Pall’s アレグロ™ single-use systems provide essential assistance in order to facilitate quick product manufacture and increased capacity - of critical importance during pandemic outbreaks.  

インフルエンザのワクチン製造技術の選択ガイド

当社のワクチン製造技術の詳細については、下のボタンをクリックしてください。